After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Drug Manufacturers – General industry segment, falling under the Healthcare sector. The current market capitalization of Gilead Sciences, Inc is $154.20B. A total of 24.23 million shares were traded on the day, compared to an average of 7.35M shares.
In the most recent transaction, Dickinson Andrew D sold 3,000 shares of GILD for 122.00 per share on Dec 15 ’25. After the transaction, the Chief Financial Officer now owns 153,503 company shares. In a previous transaction on Dec 15 ’25, Mercier Johanna sold 3,000 shares at 122.00 per share. GILD shares that Chief Commercial Officer owns now total 106,221.
Among the insiders who bought shares, JOHANNA MERCIER acquired of 3,000 shares on Dec 15 ’25 at a per-share price of $122.00. In another insider transaction, ANDREW DICKINSON bought 3,000 shares at $122.00 per share on Dec 15 ’25.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Gilead Sciences, Inc pays an annual dividend of $3.16, resulting in a dividend yield of 2.54%, and it has a price to earnings (P/E) ratio of 19.25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, GILD has a high of $128.70 and a low of $88.57.
As of this writing, GILD has an earnings estimate of $1.89 per share for the current quarter. EPS was calculated based on a consensus of 21.0 estimates, with a high estimate of $2.16 per share and a lower estimate of $1.75. The company reported an EPS of $1.9 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. GILD’s latest balance sheet shows that the firm has $6.52B in Cash & Short Term Investments as of fiscal 2021. There were $26.70B in debt and $11.61B in liabilities at the time. Its Book Value Per Share was $17.34, while its Total Shareholder’s Equity was $21.06B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GILD is Buy with a score of 4.47.
